Transparency data
The 2024 VPAG operational review: 22 July 2024
Minutes of a meeting held between the government, NHS England and ABPI about the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG).
Documents
Details
The voluntary scheme for branded medicines pricing, access and growth (VPAG) is a non-contractual voluntary agreement between the government (constituted of the Department of Health and Social Care, NHS England and the governments of Scotland, Wales and Northern Ireland) and the Association of the British Pharmaceutical Industry (ABPI), the representative body of the UK pharmaceutical industry.
VPAG aims to:
- promote better patient outcomes and a healthier population
- support UK economic growth
- contribute to a financially sustainable NHS
Operational review meetings are held every 6 months.
Updates to this page
Published 4 October 2024